AbbVie (ABBV) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 12.8 | 2.27 | 2.75 | 25.3 | 26.7 | 26.5 | ||
| Changes by years, y/y, % | -38% | -82% | +21% | +817% | +6% | +5.0% | |||
AbbVie. EV/EBITDA
AbbVie. EV/EBITDA, changes, %
AbbVie (ABBV) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 29.4 | 27.7 | 37.0 | 26.7 | 26.6 | 26.5 | |
| Changes by years, y/y, % | +871% | +773% | +63% | +6% | -10% | |||
| Changes by quarters, q/q, % | +16% | -5% | +33% | -28% | -1% | |||